Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
Nexentis Technologies (NASDAQ: NXTS) announced that Prof. Dan T. Major has joined the Scientific Advisory Board of its wholly owned subsidiary MitoCareX Bio Ltd. Prof.
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.